Growth and Tolerance of Young Infants Fed Infant Formulas
Completed · Phase 3
Conditions studied: Infant Newborn
In brief
This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.
Key facts
- Study ID
- NCT01380886
- Run by
- Abbott Nutrition
- People needed
- 209
- Starts
- 2011-06-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2013-02-15
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- healthy infant
- full term
- birth weight > 2490 g
- 0 to 8 days of age
- parent/physician agree to not use medications affecting tolerance/growth
- parent agrees to sole source feeding of study formula
- parent agrees to not use vitamin/mineral supplements
- parent has signed consent/HIPAA authorization
You may not qualify if…
- any maternal, fetal, or infant history affecting growth and tolerance
- participation in any other study not preapproved by Abbott
Where it is running
- Norwich Pediatric Group, PC — Norwich, Connecticut, United States
- SCORE Physician Alliance, LLC — St. Petersburg, Florida, United States
- Northpoint Pedicatrics, LLC — Indianapolis, Indiana, United States
- Springs Medical Research, LLC — Owensboro, Kentucky, United States
- Clinical Research Center of Nevada — Las Vegas, Nevada, United States
- Cary Pediatric Center — Cary, North Carolina, United States
- MetroHealth Medical Center — Cleveland, Ohio, United States
- Ohio Pediatric Research Association, INC. — Huber Heights, Ohio, United States
- Institute of Clinical Research — Mayfield Heights, Ohio, United States
- The Cleveland Pediatric Research Center — Parma, Ohio, United States
- Sanford Clinic Family Medicine — Sioux Falls, South Dakota, United States
- DCOL Center for Clinical Research — Longview, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.